Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update.

ABSTRACT: In the last few decades, there has been a progressive increase in the prevalence of allergic rhinitis (AR) in China, where it now affects approximately 250 million people. AR prevention and treatment include allergen avoidance, pharmacotherapy, allergen immunotherapy (AIT), and patient education, among which AIT is the only curative intervention. AIT targets the disease etiology and may potentially modify the immune system as well as induce allergen-specific immune tolerance in patients with AR. In 2017, a team of experts from the Chinese Society of Allergy (CSA) and the Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G) produced the first English version of Chinese AIT guidelines for AR. Since then, there has been considerable progress in basic research of and clinical practi

SUBMITTER: Wang C 

PROVIDER: S-EPMC9709690 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature